Quick Takeaways
- Paul B. Manning filed SCHEDULE 13D/A for Verrica Pharmaceuticals Inc. Common Stock, $0.0001 par value per share (VRCA).
- Disclosed ownership: 50%.
- Date of event: 25 Nov 2025.
Paul B. Manning - 25 Nov 2025 SCHEDULE 13D/A Report for Verrica Pharmaceuticals Inc. Common Stock, $0.0001 par value per share (VRCA)
- Filing Manager
- Paul B. Manning
- Reporting Manager
- Paul B Manning
- Symbol
- VRCA
- Shares outstanding
- 16,144,351 shares
- Disclosed Ownership
- 8,056,031 shares
- Ownership
- 50%
- Form type
- SCHEDULE 13D/A
- Filing time
- 28 Nov 2025, 17:10:55 UTC
- Date of event
- 25 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Paul B. Manning disclosed 50% ownership in Verrica Pharmaceuticals Inc. Common Stock, $0.0001 par value per share (VRCA) on 25 Nov 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 28 Nov 2025, 17:10.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Paul B Manning | 50% | 8,056,031 | 4,681,996 | 3,374,035 | /s/ Paul B. Manning | Paul B. Manning | 0001494695 |
| PBM Capital Investments, LLC | 0.2% | 25,663 | 25,663 | 0 | /s/ Paul B. Manning | By: PBM Capital Group, LLC, its Manager, By: Paul B. Manning, Chief Executive Officer | |
| BKB Growth Investments, LLC | 21% | 3,348,372 | 3,348,372 | 0 | /s/ Paul B. Manning /s/ Bradford Manning | By: Tiger Lily Capital, LLC, its manager, By: Paul B. Manning, Manager and Bradford Manning, Manager |